19
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is CLOZAPINE, with a corresponding application number 203807.
Regulatory Information DISCN
With a dosage strength 50MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2017-08-22
18
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is CLOZAPINE, with a corresponding application number 203807.
Regulatory Information DISCN
With a dosage strength 25MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2015-09-17
17
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is CLOZAPINE, with a corresponding application number 203807.
Regulatory Information DISCN
With a dosage strength 200MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2017-08-22
16
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is CLOZAPINE, with a corresponding application number 203807.
Regulatory Information DISCN
With a dosage strength 100MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2015-09-17